Top Markets
Coin of the day
Hoth Therapeutics, Inc. Hoth Therapeutics, Inc.

Hoth Therapeutics, Inc.

HOTH
Rank in Stocks #32246
Hoth Therapeutics, Inc. engages in the development of new generation therapies... Hoth Therapeutics, Inc. engages in the development of new generation therapies for dermatological disorders. Its product pipeline focuses on potential treatments for indications including atopic dermatitis (also known as eczema), chronic wounds, psoriasis, asthma, and acne. It offers the BioLexa Platform, a drug compound platform for the treatment of eczema. The company was founded by Robbie Knie, Matthew D. Eitner, and James Ahern on May 16, 2017 and is headquartered in New York, NY.
Share Price
$0.8013
Last synced: 2026-08-05
Market Cap
$10.62M
Change (1 day)
0.97%
Change (1 year)
-37.88%
Country
US
Trade Hoth Therapeutics, Inc. (HOTH)

Category

Stock split history for Hoth Therapeutics, Inc. (HOTH)
Hoth Therapeutics, Inc. stock (symbol: HOTH) underwent a total of 0 stock splits.
The most recent stock split occurred on Aug 18, 2026.
One HOTH share bought prior to Aug 18, 2026 would equal to 0 HOTH shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
KR